146 related articles for article (PubMed ID: 19585396)
1. Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone.
Gade K; Häussinger C; Bandelow B
Pharmacopsychiatry; 2009 Jul; 42(4):164-5. PubMed ID: 19585396
[No Abstract] [Full Text] [Related]
2. Naltrexone treatment of self-injurious behavior.
Godart NT; Agman G; Perdereau F; Jeammet P
J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
[No Abstract] [Full Text] [Related]
3. Treatment of obsessive-compulsive cutting behavior with naltrexone.
Bystritsky A; Strausser BP
J Clin Psychiatry; 1996 Sep; 57(9):423-4. PubMed ID: 9746454
[No Abstract] [Full Text] [Related]
4. Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study.
Lubin G; Weizman A; Shmushkevitz M; Valevski A
Hum Psychopharmacol; 2002 Jun; 17(4):181-5. PubMed ID: 12404685
[TBL] [Abstract][Full Text] [Related]
5. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.
Eriksson T
Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461
[TBL] [Abstract][Full Text] [Related]
6. Augmentation with naltrexone to treat compulsive sexual behavior: a case series.
Raymond NC; Grant JE; Coleman E
Ann Clin Psychiatry; 2010 Feb; 22(1):56-62. PubMed ID: 20196983
[TBL] [Abstract][Full Text] [Related]
7. Dose-related exacerbation of obsessive-compulsive symptoms with quetiapine treatment.
Chen CH; Chiu CC; Huang MC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):304-5. PubMed ID: 17826882
[No Abstract] [Full Text] [Related]
8. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
[No Abstract] [Full Text] [Related]
9. Understanding and treating kleptomania: new models and new treatments.
Grant JE
Isr J Psychiatry Relat Sci; 2006; 43(2):81-7. PubMed ID: 16910369
[TBL] [Abstract][Full Text] [Related]
10. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
11. Disabling obsessive thoughts responsive to antidepressants.
Jenike MA; Armentano ME; Baer L
J Clin Psychopharmacol; 1987 Feb; 7(1):33-5. PubMed ID: 3818991
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report.
Orihuela-Flores M; Deriaz N; Carminati GG
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1137-8. PubMed ID: 20460140
[No Abstract] [Full Text] [Related]
13. Naltrexone for the treatment of trichotillomania: a case report.
Carrion VG
J Clin Psychopharmacol; 1995 Dec; 15(6):444-5. PubMed ID: 8748437
[No Abstract] [Full Text] [Related]
14. Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.
Anholt GE; van Oppen P; Emmelkamp PM; Cath DC; Smit JH; van Dyck R; van Balkom AJ
J Anxiety Disord; 2009 Aug; 23(6):830-5. PubMed ID: 19443176
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.
Sasso DA; Kalanithi PS; Trueblood KV; Pittenger C; Kelmendi B; Wayslink S; Malison RT; Krystal JH; Coric V
J Clin Psychopharmacol; 2006 Dec; 26(6):685-7. PubMed ID: 17110840
[No Abstract] [Full Text] [Related]
16. [The treatment of hypersexuality in a male with obsessive compulsive disorder as psychiatric co-morbidity].
Jairam J; van Marle HJ
Tijdschr Psychiatr; 2008; 50(2):113-7. PubMed ID: 18264903
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic challenges in comorbid obsessive compulsive disorder with substance use.
Jain S; Gupta T; Nebhinani N; Singhai K; Suthar N
Asian J Psychiatr; 2018 Jan; 31():127-128. PubMed ID: 29482123
[No Abstract] [Full Text] [Related]
18. Naltrexone for the treatment of obesity: review and update.
Lee MW; Fujioka K
Expert Opin Pharmacother; 2009 Aug; 10(11):1841-5. PubMed ID: 19537999
[TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
20. Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial.
Zhang ZJ; Wang XY; Tan QR; Jin GX; Yao SM
J Nerv Ment Dis; 2009 Aug; 197(8):619-22. PubMed ID: 19684500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
